Does REPOTRECTINIB Cause Muscular weakness? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Muscular weakness have been filed in association with REPOTRECTINIB (Augtyro). This represents 4.3% of all adverse event reports for REPOTRECTINIB.
8
Reports of Muscular weakness with REPOTRECTINIB
4.3%
of all REPOTRECTINIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Muscular weakness From REPOTRECTINIB?
Of the 8 reports, 1 (12.5%) required hospitalization.
Is Muscular weakness Listed in the Official Label?
Yes, Muscular weakness is listed as a known adverse reaction in the official FDA drug label for REPOTRECTINIB.
What Other Side Effects Does REPOTRECTINIB Cause?
Dizziness (32)
Death (21)
Nausea (12)
Adverse event (11)
Neuropathy peripheral (11)
Off label use (10)
Paraesthesia (10)
Balance disorder (9)
Pain (9)
Hospitalisation (8)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which REPOTRECTINIB Alternatives Have Lower Muscular weakness Risk?
REPOTRECTINIB vs REQUIP
REPOTRECTINIB vs RESLIZUMAB
REPOTRECTINIB vs RESMETIROM
REPOTRECTINIB vs RESTASIS
REPOTRECTINIB vs RETINOL